Cargando…

Genetics of Familial Hypercholesterolemia: New Insights

Familial hypercholesterolemia (FH) is one of the most common monogenic diseases, leading to an increased risk of premature atherosclerosis and its cardiovascular complications due to its effect on plasma cholesterol levels. Variants of three genes (LDL-R, APOB and PCSK9) are the major causes of FH,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vrablik, Michal, Tichý, Lukas, Freiberger, Tomas, Blaha, Vladimir, Satny, Martin, Hubacek, Jaroslav A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575810/ https://www.ncbi.nlm.nih.gov/pubmed/33133164 http://dx.doi.org/10.3389/fgene.2020.574474

Ejemplares similares

Editorial: Genetics of Familial Hypercholesterolemia: New Insight
por: Vuorio, Alpo, et al.
Publicado: (2021)

Editorial: Genetics of familial hypercholesterolemia: New insight—Volume II
por: Vuorio, Alpo, et al.
Publicado: (2022)

Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part I: Genetics and Biochemical Parameters
por: Todorovova, Veronika, et al.
Publicado: (2022)

Multiplex Protein Biomarker Profiling in Patients with Familial Hypercholesterolemia
por: Dlouha, Dana, et al.
Publicado: (2021)

Genomic characterization of large rearrangements of the LDLR gene in Czech patients with familial hypercholesterolemia
por: Goldmann, Radan, et al.
Publicado: (2010)

Genetics of Hypercholesterolemia: Comparison Between Familial Hypercholesterolemia and Hypercholesterolemia Nonrelated to LDL Receptor
por: Jarauta, Estíbaliz, et al.
Publicado: (2020)

Familial Hypercholesterolemia: Real-World Data of 1236 Patients Attending a Czech Lipid Clinic. A Retrospective Analysis of Experience in More than 50 years. Part II. Clinical Characteristics
por: Altschmiedova, Tereza, et al.
Publicado: (2022)

Genetic Diagnosis of Familial Hypercholesterolemia in Asia
por: Huang, Chin-Chou, et al.
Publicado: (2020)

Long-Term LDL-Apheresis Treatment and Dynamics of Circulating miRNAs in Patients with Severe Familial Hypercholesterolemia
por: Dlouha, Dana, et al.
Publicado: (2023)

Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry
por: Truong, Thanh-Huong, et al.
Publicado: (2020)

Familial Hypercholesterolemia in Russia: Three Decades of Genetic Studies
por: Vasilyev, Vadim, et al.
Publicado: (2020)

Reporting LDL cholesterol results by clinical biochemistry laboratories in Czechia and Slovakia to improve the detection rate of familial hypercholesterolemia
por: Šálek, Tomáš, et al.
Publicado: (2023)

Fast and Easy Nanopore Sequencing Workflow for Rapid Genetic Testing of Familial Hypercholesterolemia
por: Soufi, Muhidien, et al.
Publicado: (2022)

Low Density Lipoprotein Receptor Variants in the Beta-Propeller Subdomain and Their Functional Impact
por: Dušková, Lucie, et al.
Publicado: (2020)

The Prevalence and Genetic Spectrum of Familial Hypercholesterolemia in Qatar Based on Whole Genome Sequencing of 14,000 Subjects
por: Diboun, Ilhame, et al.
Publicado: (2022)

Low LDL-C goal attainment in patients at very high cardiovascular risk due to lacking observance of the guidelines on dyslipidaemias
por: Vrablík, Michal, et al.
Publicado: (2023)

PCSK9 Variants in Familial Hypercholesterolemia: A Comprehensive Synopsis
por: Guo, Qianyun, et al.
Publicado: (2020)

Effects of Different Types of Pathogenic Variants on Phenotypes of Familial Hypercholesterolemia
por: Tada, Hayato, et al.
Publicado: (2022)

Two Novel Disease-Causing Mutations in the LDLR of Familial Hypercholesterolemia
por: Hu, Haochang, et al.
Publicado: (2021)

Implementation of a biochemical, clinical, and genetic screening programme for familial hypercholesterolemia in 26 centres in Spain: The ARIAN study
por: Arrobas Velilla, Teresa, et al.
Publicado: (2022)

Familial Hypercholesterolemia Prevalence Among Ethnicities—Systematic Review and Meta-Analysis
por: Toft-Nielsen, Frida, et al.
Publicado: (2022)

The Digenic Causality in Familial Hypercholesterolemia: Revising the Genotype–Phenotype Correlations of the Disease
por: Kamar, Amina, et al.
Publicado: (2021)

Genetic and Clinical Characteristics of Patients With Homozygous and Compound Heterozygous Familial Hypercholesterolemia From Three Different Populations: Case Series
por: Marusic, Tatiana, et al.
Publicado: (2020)

The risk of various types of cardiovascular diseases in mutation positive familial hypercholesterolemia; a review
por: Hovland, Anders, et al.
Publicado: (2022)

Early Discovery of Children With Lysosomal Acid Lipase Deficiency With the Universal Familial Hypercholesterolemia Screening Program
por: Sustar, Ursa, et al.
Publicado: (2022)

Genetics of Cardiovascular Disease: How Far Are We from Personalized CVD Risk Prediction and Management?
por: Vrablik, Michal, et al.
Publicado: (2021)

Genetically confirmed familial hypercholesterolemia in outpatients with hypercholesterolemia
por: Wang, Xu, et al.
Publicado: (2018)

Proteostasis Regulation in the Endoplasmic Reticulum: An Emerging Theme in the Molecular Pathology and Therapeutic Management of Familial Hypercholesterolemia
por: Oommen, Deepu, et al.
Publicado: (2020)

Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care
por: Loh, Wann Jia, et al.
Publicado: (2022)

Identification and Functional Characterization of a Low-Density Lipoprotein Receptor Gene Pathogenic Variant in Familial Hypercholesterolemia
por: Shu, Hong-Yan, et al.
Publicado: (2021)

Do Biobank Recall Studies Matter? Long-Term Follow-Up of Research Participants With Familial Hypercholesterolemia
por: Nurm, Miriam, et al.
Publicado: (2022)

Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
por: Banach, Maciej, et al.
Publicado: (2020)

Low Detection Rates of Genetic FH in Cohort of Patients With Severe Hypercholesterolemia in the United Arabic Emirates
por: Rimbert, Antoine, et al.
Publicado: (2022)

Analysis of Differentially Expressed Genes and Molecular Pathways in Familial Hypercholesterolemia Involved in Atherosclerosis: A Systematic and Bioinformatics Approach
por: Udhaya Kumar, S., et al.
Publicado: (2020)

The Role of Registers in Increasing Knowledge and Improving Management of Children and Adolescents Affected by Familial Hypercholesterolemia: the LIPIGEN Pediatric Group
por: Gazzotti, Marta, et al.
Publicado: (2022)

Genetic Testing in Familial Hypercholesterolemia: Is It for Everyone?
por: Medeiros, A. M., et al.
Publicado: (2023)

Mutational Spectrum of LDLR and PCSK9 Genes Identified in Iranian Patients With Premature Coronary Artery Disease and Familial Hypercholesterolemia
por: Moradi, Arman, et al.
Publicado: (2021)

Corrigendum: The role of registers in increasing knowledge and improving management of children and adolescents affected by familial hypercholesterolemia: The LIPIGEN pediatric group
por: Gazzotti, Marta, et al.
Publicado: (2023)

The genetic spectrum of familial hypercholesterolemia in Pakistan
por: Ahmed, Waqas, et al.
Publicado: (2013)

The genetics of familial hypercholesterolemia and emerging therapies
por: Vogt, Anja
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fnqaj6s7a317m2lgg1m8b4qh8j